KRYS Krystal Biotech Inc
Company Analysis
Latest News
Krystal Biotech director sells $8.2M in shares, RBC upgrades stock
Director Dino Rossi sold 25,000 shares of Krystal Biotech, Inc. on August 14, 2026. The transaction totaled approximately $8.23 million at a price of $329.12...
Krystal Biotech Eyes $400 Target, Citing Strong VYJUVEK Revenue
RBC Capital initiated coverage of Krystal Biotech (KRYS) on Friday. The firm issued an Outperform rating. Analysts set a price target of $400 for the...
Krystal Biotech's Gene Therapy Growth Story Hits a Speed Bump — Is the Sell-Off an Overreaction or a Warning Sign?
Shares shifted sharply lower as Krystal Biotech dropped 6.8% to $318.01 after posting second-quarter results that forced investors to weigh strong profits...
🟢 Krystal Biotech is trading 4.2% up today, rebounding from a post-earnings selloff
Krystal Biotech is trading 4.2% up at $325.83, recovering from a sharp decline following its second-quarter financial results. • Investors are reassessing the...
🔴 Krystal Biotech is trading 10.1% down today as revenue misses consensus despite EPS beat
Krystal Biotech is trading 10.1% down today at $306.65 after reporting second-quarter 2026 earnings where revenue slightly missed analyst expectations. •...
🔴 Krystal Biotech is trading 5.7% down today on mixed Q2 results and revenue miss
Krystal Biotech is trading 5.7% down at $320.00 following a mixed second-quarter 2026 earnings report that saw revenue fall short of analyst estimates. •...
🔴 Krystal Biotech is trading 6.8% down today after Q2 revenue misses expectations
Krystal Biotech is trading at $318.01 (6.8% down) today after reporting mixed second-quarter 2026 results where a revenue miss overshadowed an earnings...
Krystal Biotech's second quarter revenue of $119.2M missed estimates, while EPS of $1.79 beat.
Krystal Biotech reported mixed second quarter 2026 results, with its key product VYJUVEK missing revenue expectations while earnings per share came in ahead of...
🟢 Krystal Biotech is trading 5% up today ahead of Q2 earnings and rebounding from recent losses
Krystal Biotech is trading at $358.00 (5% up) in pre-market, rebounding from a 7% drop in the previous session as investors position ahead of the company's Q2...
Krystal Biotech Inc Q2 2026 Earnings Preview: What Analysts Expect on August 03, 2026
Consensus expectations for Krystal Biotech’s Q2 2026 earnings include revenue of $122.61 million and earnings of $1.70 per share, with the stock trading at...
🔴 Krystal Biotech is trading 5.2% down today amid broader biotech sector weakness
Krystal Biotech is trading at $347.76 (-5.20%) following a sharp intraday drop that appears driven by broader industry trends rather than company-specific...
🟢 Krystal Biotech is trading 6.4% up today extending recent momentum without a clear catalyst
Krystal Biotech is trading at $387.38 (+6.36%) in pre-market, continuing a multi-day rally despite the absence of new company-specific announcements. • The...
🔴 Krystal Biotech is trading 5.1% down today after its recent index-addition rally
Krystal Biotech is trading 5.1% down at $334.00 in after-hours as it gives back gains from its recent rally following its addition to the S&P MidCap 400. •...
🟢 Krystal Biotech is trading 4.1% up today amid a bullish biotech tape and risk-on sentiment
Krystal Biotech is trading at $348.82 (4.1% up), extending its recent upward trajectory following its addition to the S&P MidCap 400 and a strong performance...
🟢 Krystal Biotech is trading 6.7% up today amid a broader risk-on market session
Krystal Biotech is trading at $357.52 (+6.66%) in pre-market, moving higher despite a lack of company-specific catalysts such as earnings, FDA news, or analyst...
🔴 Krystal Biotech is trading 4.3% down today as pre-market gains fade
Krystal Biotech is trading at $339.56 (4.3% down) today after a strong pre-market move higher faded during the regular trading session. • There are no new...
🟢 Krystal Biotech is trading 4.8% up today with no clear catalyst
Krystal Biotech is trading 4.8% up at $371.96 in pre-market, extending last week’s strength despite a lack of fresh company-specific headlines or catalysts. •...
🟢 Krystal Biotech is trading 4.03% up today with no clear company-specific catalyst
Krystal Biotech is trading at $355.57 (+4.03%) today, with the move appearing to be driven by broader market flow rather than a specific company catalyst. •...
🔴 Krystal Biotech is trading 5% down today amid broader risk-off sentiment
Krystal Biotech is trading at $324.06 (5% down) in pre-market action, following several days of volatility after a strong multi-quarter run. • The move...
🔴 Krystal Biotech is trading 4.5% down today on sector-wide profit-taking
Krystal Biotech is trading 4.5% down at $347.19 as the stock gives back recent gains amid a broader pullback in high-beta biotech names. • The decline follows...